+44 (0) 28 9442 2413 Click here to view Randox Chinese website Click here to view Randox French website Click here to view Randox Polish website Click here to view Randox South Korea website
Reagents
Metabolic Syndrome Arrays
Metabolic Syndrome Arrays
Contact Randox

View Brochure:

 

For simultaneous determination of analytes associated with metabolic syndrome and related disorders

About Randox Metabolic Syndrome Arrays

Metabolic Syndrome is a clustering of cardiovascular risk factors and with approximately 20-25% of adults affected, it is highly prevalent. It is estimated that having Metabolic Syndrome leads to a person being three times more likely to have a stroke or heart attack and five times more likely to develop diabetes. However, the pathophysiological processes leading to Metabolic Syndrome remain unclear, with no universally accepted definition.

Metabolic Syndrome has been defined by various different expert groups and associations each using different sets of criteria, which reflect the contrasting views on the pathological mechanisms and clinical application. However, the International Diabetes Federation (IDF) have proposed a worldwide definition which states that in order to have Metabolic Syndrome, a person must have central obesity plus two of the following four factors; raised triglycerides, reduced HDL cholesterol, raised blood pressure and raised fasting plasma glucose.

Benefits of Randox Metabolic Syndrome Array

  • Multiple assays from one sample using Biochip Array Technology
  • Analytes have been carefully selected for application to a wide range of clinical research studies
  • Suitable for both serum and plasma samples
  • Small sample volume - 100 μl to measure all analytes on each array
  • Very efficient use of highly valuable patient sample banks
  • Biochips are ready to use, saving time and resources
  • Semi-automated analyser requiring minimal maintenance
  • Quick time to results
  • Multi-analyte controls and calibrators available
  • Excellent assay performance
  • Range of associated arrays available for comprehensive studies
  • No none-specific aggregation associated with multi-analyte bead assays

Metabolic Syndrome Array I

  • C-peptide
  • Ferritin
  • Interleukin-1α (IL-1α)
  • Interleukin-6 (IL-6)
  • Insulin
  • Leptin
  • Plasminogen Activator Inhibitor-1 (PAI-1)
  • Resistin
  • Tumour Necrosis Factor α (TNFα)

Metabolic Syndrome Array II

  • Adiponectin
  • C-reactive Protein (CRP)
  • Cystatin C

Available Downloads

Products

Contract Manufacturing

Product List 2014

Randox Engineering Randox accreditations